Drug intelligence / Profile preview

flucytosine

Development stage
Approved
Lead developer
Roche
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Flucytosine is an antifungal small molecule used primarily to treat serious systemic infections caused by susceptible strains of Candida and Cryptococcus species. It is often administered in combination with amphotericin B for enhanced efficacy, particularly in the treatment of cryptococcal meningitis and other severe fungal infections. Flucytosine acts as an antimetabolite; it enters fungal cells via cytosine permease and is converted intracellularly into 5-fluorouracil (5-FU). The active metabolites disrupt both RNA and DNA synthesis by being incorporated into fungal RNA (as 5-fluorouridinetriphosphate) and inhibiting thymidylate synthase (via 5-fluorodeoxyuridinemonophosphate), leading to impaired protein synthesis and cell death. Resistance can develop rapidly if used as monotherapy.

Brand names
Ancobon
Other names
flucytosine5-fluorocytosine5-FC
02

Targets

TS (Thymidylate synthase)Purine-cytosine permease (FCY2)

Beyond the preview

Go deeper on flucytosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flucytosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call